Addex Therapeutics SEC Filings
NASDAQ: ADXNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.47+0.07 (+2.06%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Addex Therapeutics filing overview
This page lists 60 recent SEC filings by Addex Therapeutics (ADXN), including 35 6-K, 15 4, 3 SCHEDULE 13D/A, 2 4/A. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
ADXN SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Nov 16, 2026 | 4/A | Statement of changes in beneficial ownership (amendment) | View on EDGAR |
| Nov 16, 2026 | 4/A | Statement of changes in beneficial ownership (amendment) | View on EDGAR |
| Nov 13, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Nov 13, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Nov 13, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Nov 13, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Nov 13, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Nov 13, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Nov 13, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Nov 12, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Oct 29, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Oct 8, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Oct 2, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 28, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 25, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 4, 2026 | SCHEDULE 13D/A | Beneficial ownership report (activist) (amendment) | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Sep 4, 2026 | 4 | OWNERSHIP DOCUMENT | View on EDGAR |
| Aug 27, 2026 | SCHEDULE 13D/A | Beneficial ownership report (activist) (amendment) | View on EDGAR |
| Aug 26, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 8, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 30, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 25, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 5, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| May 15, 2026 | 20-F | Annual report (foreign private issuer) | View on EDGAR |
| Apr 30, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Apr 29, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Apr 23, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Apr 21, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Feb 3, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jan 7, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Dec 10, 2025 | 424B5 | Prospectus | View on EDGAR |
| Dec 10, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Dec 4, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Oct 29, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 30, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 23, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 30, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 25, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 23, 2025 | SCHEDULE 13D/A | Beneficial ownership report (activist) (amendment) | View on EDGAR |
| Jun 20, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 6, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| May 15, 2025 | 20-F | Annual report (foreign private issuer) | View on EDGAR |
| May 12, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Apr 30, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Apr 25, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Apr 17, 2025 | 6-K | Report of foreign private issuer | View on EDGAR |
| Nov 22, 2024 | 6-K | Report of foreign private issuer | View on EDGAR |
| Nov 12, 2024 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 30, 2024 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 19, 2024 | 6-K | Report of foreign private issuer | View on EDGAR |
| Aug 27, 2024 | 6-K | Report of foreign private issuer | View on EDGAR |
| Aug 14, 2024 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) | View on EDGAR |
| Aug 5, 2024 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) | View on EDGAR |